First Financial Equity Corporation’s Gilead Sciences GILD Stock Holding History

First Financial Equity Corporation’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1.02M	Buy	+15,173	New	+$1.07M	0.17%	137

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

First Financial Equity Corporation's GILD Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Gilead Sciences (GILD) in Q1 2017: 15,173 shares worth $1.02M. The stake represents 0.17% of the portfolio and ranks #137 among its holdings.

1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

First Financial Equity Corporation held 15,173 shares of Gilead Sciences worth $1.02M as of Q1 2017.
Gilead Sciences was a new First Financial Equity Corporation position in Q1 2017.
Gilead Sciences made up 0.17% of First Financial Equity Corporation's portfolio in Q1 2017, its #137 holding.
1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.